Ethnic differences in pharmacogenomic variants: a south Asian perspective

References

• Schwarz UI , GulilatM , KimRB. The role of next-generation sequencing in pharmacogenetics and pharmacogenomics. Cold Spring Harb. Perspect. Med.9(2), doi: 10.1101/cshperspect.a033027 (2019).
   PubMed Web of Science ®Google Scholar
• Roden DM , GeorgeALJr. The genetic basis of variability in drug responses. Nat. Rev. Drug Discov.1(1), 37–44 (2002).
   PubMed Web of Science ®Google Scholar
• Caudle KE , KleinTE , HoffmanJMet al. Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process. Curr. Drug Metab.15(2), 209–17 (2014). https://cpicpgx.org/guidelines/
   PubMed Web of Science ®Google Scholar
• CPIC . Guidelines. https://cpicpgx.org/guidelines/
   Google Scholar
• US Food and Drug Administration Center for Drug Evaluation Research . Table of pharmacogenomic biomarkers in drug labeling (2023). www.fda.gov/drugs/science-and-research-drugs/table-pharmacogenomic-biomarkers-drug-labeling
   Google Scholar
• Sharma S , Mariño-RamírezL , JordanIK. Race, ethnicity, and pharmacogenomic variation in the United States and the United Kingdom. Pharmaceutics15(7), doi: 10.3390/pharmaceutics15071923 (2023).
   Web of Science ®Google Scholar
• Thiers FA , SinskeyAJ , BerndtER. Trends in the globalization of clinical trials. Nat. Rev. Drug Discov.7(1), 13–14.
   Web of Science ®Google Scholar
• Edwards IR , AronsonJK. Adverse drug reactions: definitions, diagnosis, and management. Lancet356(9237), 1255–1259 (2000).
   PubMed Web of Science ®Google Scholar
• Worldometer . www.worldometers.info/world-population/southern-asia-population/
   Google Scholar
• Ferrell PB Jr , McLeodHL. Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations. Pharmacogenomics9(10), 1543–6 (2008).
   PubMed Web of Science ®Google Scholar
• Tantular IS , KawamotoF. Distribution of G6PD deficiency genotypes among Southeast Asian populations.Trop. Med. Health49(1), 97 (2021).
   PubMed Web of Science ®Google Scholar
• Hariprakash JM , VellarikkalSK , KeechilatPet al. Pharmacogenetic landscape of DPYD variants in south Asian populations by integration of genome-scale data. Pharmacogenomics19(3), 227–241 (2018).
   PubMed Web of Science ®Google Scholar
• Biswas M , JindaP , SukasemC. Pharmacogenomics in Asians: differences and similarities with other human populations. Expert Opin. Drug Metab. Toxicol.19(1), 27–41 (2023).
   PubMed Web of Science ®Google Scholar
• Ahsan T , SajibAA. Drug-response related genetic architecture of Bangladeshi population. Meta Gene21, 100585 (2019).
   Web of Science ®Google Scholar
• Dorji PW , WangchukS , BoonprasertK , TarasukM , Na-BangchangK. Pharmacogenetic relevant polymorphisms of CYP2C9, CYP2C19, CYP2D6, and CYP3A5 in Bhutanese population. Drug Metab. Pers. Ther.34(4), doi: 10.1515/dmpt-2019-0020 (2019).
   PubMedGoogle Scholar
• Khan AR , ShahSH , AjazS , FirasatS , AbidA , RazaA. The prevalence of pharmacogenomics variants and their clinical relevance among the Pakistani population. Evol. Bioinform. Online18, 11769343221095834 (2022).
   Web of Science ®Google Scholar
• Ranasinghe P , SirisenaN , AriaduraiJNet al. Pharmacogenomic variants affecting efficacy and toxicity of statins in a south Asian population from Sri Lanka. Pharmacogenomics24(15), 809–819 (2023).
   PubMedGoogle Scholar
• Sivadas A , ScariaV. Pharmacogenomic survey of Qatari populations using whole-genome and exome sequences. Pharmacogenomics J.18(4), 590–600 (2018).
   PubMed Web of Science ®Google Scholar
• Jithesh PV , AbuhaliqaM , SyedNet al. A population study of clinically actionable genetic variation affecting drug response from the Middle East. NPJ Genomic Med.7(1), 1–11 (2022).
   PubMed Web of Science ®Google Scholar
• Bhasin MK . Genetics of Castes and Tribes of India: Somatometry. International Journal of Human Genetics6(4), 323–356 (2006).
   Google Scholar
• Shewade DG . Status of pharmacogenomics research in India during the last five years. Proc. Indian Natl Sci. Acad.95, doi: 10.16943/PTINSA/2017/49229 (2017).
   Google Scholar
• Sharma A , KumariKM , ManoharHD , BairyKL , ThomasJ. Pattern of adverse drug reactions due to cancer chemotherapy in a tertiary care hospital in south India. Perspect. Clin. Res.6(2), 109–115 (2015).
   PubMedGoogle Scholar
• Saini VK , SewalRK , AhmadY , MedhiB. Prospective observational study of adverse drug reactions of anticancer drugs used in cancer treatment in a tertiary care hospital. Indian J. Pharm. Sci.77(6), 687–693 (2015).
   PubMed Web of Science ®Google Scholar
• Sahana S , BhoyarRC , SivadasAet al. Pharmacogenomic landscape of Indian population using whole genomes. Clin. Transl. Sci.15(4), 866–877 (2022).
   PubMed Web of Science ®Google Scholar
• van Dyck CH , SwansonCJ , AisenPet al. Lecanemab in early Alzheimer’s disease. N. Engl. J. Med. doi: 10.1056/NEJMoa2212948 (2022).
   PubMedGoogle Scholar
• Jolly B , ScariaV. Letter to the editor: Alzheimer’s disease-associated APOE ε4 frequencies in Indian population genomes may suggest implications in lecanemab treatment. J. Prev. Alzheimers Dis. doi: 10.14283/jpad.2023.122 (2023).
   Web of Science ®Google Scholar
• Ramaiah M , RamakrishnaP. Pseudocholinesterase deficiency in an Indian community. J. Pharm. Pract. Community Med.3(1), 27–30 (2017).
   Google Scholar
• Al-Mahayri ZN , PatrinosGP , WattanapokayakitSet al. Variation in 100 relevant pharmacogenes among Emiratis with insights from understudied populations. Sci. Rep.10(1), 1–15 (2020).
   PubMed Web of Science ®Google Scholar
• Jain A , BhoyarRC , PandhareKet al. IndiGenomes: a comprehensive resource of genetic variants from over 1000 Indian genomes. Nucleic Acids Res.49(D1), D1225–D1232 (2021).
   PubMed Web of Science ®Google Scholar
• Wong L-P , OngRT-H , PohW-Tet al. Deep whole-genome sequencing of 100 southeast Asian Malays. Am. J. Hum. Genet.92(1), 52–66 (2013).
   PubMed Web of Science ®Google Scholar
• Le VS , TranKT , BuiHTPet al. A Vietnamese human genetic variation database. Hum. Mutat.40(10), 1664–1675 (2019).
   PubMed Web of Science ®Google Scholar
• Genomics Thailand . https://genomicsthailand.com/
   Google Scholar
• Keeling NJ , RosenthalMM , West-StrumD , PatelAS , HaidarCE , HoffmanJM. Preemptive pharmacogenetic testing: exploring the knowledge and perspectives of US payers. Genet. Med.21(5), 1224–1232 (2019).
   PubMed Web of Science ®Google Scholar
• Nogueiras-Álvarez R . Pharmacogenomics in clinical trials: an overview. Front. Pharmacol.14, 1247088 (2023).
   PubMed Web of Science ®Google Scholar
• Simeonidis S , KoutsilieriS , VozikisA , CooperDN , MitropoulouC , PatrinosGP. Application of economic evaluation to assess feasibility for reimbursement of genomic testing as part of personalized medicine interventions. Front. Pharmacol.10, 830 (2019).
   PubMed Web of Science ®Google Scholar